New Zealand clamps down on 'legal' highs

New Zealand introduced a new law on Thursday which bans the use of drugs offering so-called "legal" highs unless manufacturers can provide clinical evidence that they are safe.

The law imposes strict controls on products such as synthetic and legal "party pills", which mimic the effects of drugs like without using illicit substances.

"These products have had a shocking effect on young people and their families," Associate Health Minister Todd McClay said.

"Up until now, frontline officers have had to deal with the consequences," he continued. "Now police can be proactive, and with the help of the public we can ensure that this new law is successfully enforced."

McClay said he had received accounts of children as young as 11 becoming addicted to the , but New Zealand's "world-leading" legislation would address the problem.

"The sooner this dangerous muck is out of our dairies (newsagents) and corner stores the better," he said.

Previously, authorities had to prove a synthetic drug was harmful before ordering it off the shelves.

Under the new law, all synthetic will be illegal until their producers can provide clinical proof, such as toxicology reports and evidence from trial studies, that they are safe.

The department of health has estimated that carrying out such tests will cost manufacturers up to NZ$2 million ($1.6 million) for each synthetic , effectively deterring them from trying to sell such substances in New Zealand.

The law also stops the products being sold to minors and bans them from easily accessible retail outlets such as service stations and convenience stores.


Explore further

Australia cracks down on synthetic drugs

© 2013 AFP

Citation: New Zealand clamps down on 'legal' highs (2013, July 18) retrieved 20 June 2021 from https://medicalxpress.com/news/2013-07-zealand-clamps-legal-highs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments